IO Biotech, Inc.IOBTNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank40
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P40
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | -0.06% |
| 2023 | -4.35% |
| 2022 | 115.65% |
| 2021 | 559.25% |
| 2020 | -14.93% |
| 2019 | 0.00% |